Stock fundamentals · FY2026 · SEC 10-K data

LAM RESEARCH CORPORATION (LRCX) stock fundamentals

LAM RESEARCH CORPORATION (LRCX) reported $23.2B in revenue and $7.3B in net income in fiscal 2026, a 31.3% net margin, per its latest SEC 10-K filing. It carries a market capitalization of about $436.5B at a delayed share price. It scores 71/100 on WealthyBud's Investor Score, ranking #8 of 103 covered companies. Score is research, not investment advice.

Revenue (FY2026)
$23.2B
▲ +26.0% YoY
Net income
$7.3B
31.3% net margin
Market cap
$436.5B
Price $348.83 · delayed
P/E ratio
60.1
Price / earnings
Return on equity
58%
Net income / equity
Investor Score
71/100
#8 of 103 covered

LAM RESEARCH CORPORATION fundamentals at a glance

The table summarizes LAM RESEARCH CORPORATION's key financial figures for fiscal 2026 — revenue, profitability, returns, growth and balance-sheet strength — each taken from the company's SEC 10-K filing.

LAM RESEARCH CORPORATION (LRCX) fundamentals — FY2026, from SEC 10-K
MetricValueDetail
Revenue$23.2B+26.0% YoY
Net income$7.3B31.3% margin
Gross margin50.5%Gross profit / revenue
Operating margin35.3%Operating income / revenue
Return on equity58%Net income / equity
Return on assets31%Net income / assets
Revenue growth (YoY)+26.0%FY2025 to FY2026
Revenue 3-yr CAGR+10.1%Compound annual
Diluted EPS$5.76FY2026
Debt-to-equity0.30Long-term debt / equity
Current ratio2.63Current assets / liabilities
Cash & equivalents$5.6BBalance sheet
Total assets$23.5BFY2026 year-end
Shareholders’ equity$12.5BFY2026 year-end
Share price$348.83Delayed · 2026-10-02
Market cap$436.5BPrice × shares outstanding
P/E ratio60.1Market cap / net income
P/S ratio18.8Market cap / revenue
Dividend yield0.30%Dividend / price

How profitable is LAM RESEARCH CORPORATION?

LAM RESEARCH CORPORATION posted a 31.3% net margin and a 50.5% gross margin in fiscal 2026, turning $23.2B of revenue into $7.3B of net income. Its return on equity was 58% and its return on assets 31%.

Is LAM RESEARCH CORPORATION growing?

LAM RESEARCH CORPORATION's revenue changed +26.0% in fiscal 2026 and compounded at +10.1% a year over three years, reaching $23.2B. Diluted earnings per share were $5.76 for the year.

LAM RESEARCH CORPORATION annual revenue, 2022–2026
Fiscal yearRevenueGrowth
2022$17.2BFirst year shown
2023$17.4B+1.2%
2024$14.9B-14.5%
2025$18.4B+23.7%
2026$23.2B+26.0%

How is LAM RESEARCH CORPORATION valued?

LAM RESEARCH CORPORATION carries a market capitalization of $436.5B at a delayed share price of $348.83. It trades at 60.1 times earnings and 18.8 times sales. Its dividend yield is 0.30%. Its Value subscore is 11/100 across the covered universe.

How financially healthy is LAM RESEARCH CORPORATION?

LAM RESEARCH CORPORATION ended fiscal 2026 with $5.6B in cash, a debt-to-equity ratio of 0.30 and a current ratio of 2.63. Lower leverage and a current ratio above 1.0 signal a stronger balance sheet.

What is LAM RESEARCH CORPORATION's Investor Score?

LAM RESEARCH CORPORATION scores 71/100 on WealthyBud's Investor Score, #8 of 103 covered companies as of 2026-10-02. The score blends growth, profitability, returns on capital, balance-sheet strength and value into one percentile. It is a research opinion, not investment advice.

Investor Score
71/100
#8 of 103 covered companies
Growth
82
Profitability
69
Returns on capital
94
Balance-sheet strength
85
Value (valuation)
11

Subscores are percentile ranks (0–100) across the 103 covered companies, computed from the SEC fundamentals and delayed market price cited on this page. Data-derived opinion, not investment advice.

LAM RESEARCH CORPORATION (LRCX) stock FAQ

How much revenue does LAM RESEARCH CORPORATION make?
LAM RESEARCH CORPORATION (LRCX) reported $23.2B in revenue in fiscal 2026, +26.0% versus the prior year, according to its SEC 10-K filing. Its revenue compounded at +10.1% a year over three years.
Is LAM RESEARCH CORPORATION profitable?
Yes. LAM RESEARCH CORPORATION earned $7.3B in net income in fiscal 2026, a 31.3% net margin. Its return on equity was 58% and its return on assets 31%. These figures come from its latest 10-K.
How fast is LAM RESEARCH CORPORATION growing?
LAM RESEARCH CORPORATION's revenue changed +26.0% year over year in fiscal 2026 and compounded at +10.1% a year over three years. Growth is one of five inputs to its WealthyBud Investor Score, scored 82/100 versus the covered universe.
What is LAM RESEARCH CORPORATION's market cap and P/E ratio?
LAM RESEARCH CORPORATION has a market capitalization of $436.5B at a delayed share price of $348.83. It trades at 60.1 times earnings and 18.8 times sales. Its dividend yield is 0.30%. Prices are delayed and illustrative.
What is LAM RESEARCH CORPORATION's WealthyBud Investor Score?
LAM RESEARCH CORPORATION scores 71/100, ranking #8 of 103 covered companies as of 2026-10-02. The score is a percentile blend of growth (82), profitability (69), returns on capital (94), balance-sheet strength (85) and value (11). It is a research opinion, not investment advice.
Where does this LAM RESEARCH CORPORATION financial data come from?
Fundamentals come from LAM RESEARCH CORPORATION's annual report (Form 10-K) filed with the SEC, via the public-domain EDGAR database. The share price used for market cap, P/E and yield is a delayed end-of-day quote, shown as illustrative; a production site would use a licensed real-time market-data feed.
Fundamentals are drawn from LAM RESEARCH CORPORATION’s FY2026 Form 10-K filed with the SEC (EDGAR, public domain), retrieved 2026-10-02. Share price is a delayed end-of-day quote; market cap, P/E, P/S and dividend yield are illustrative and not real-time. The Investor Score is a data-derived research opinion. Not investment advice.

More large-cap stocks

Darius Okafor Healthcare Sector Analyst

Darius Okafor is a healthcare sector analyst who covers pharmaceutical, biotech and healthcare-services equities, focusing on revenue durability and margin trends. He builds his coverage from public SEC filings and FDA disclosures.

Editorial persona: WealthyBud bylines are editorial personas, not real individuals. Pages are produced by the WealthyBud research team from the public data cited on each page.